CA2005950A1 - Arn du genome du virus de l'hepatie non a, non b, adn-c et proteine antigenique du virus - Google Patents

Arn du genome du virus de l'hepatie non a, non b, adn-c et proteine antigenique du virus

Info

Publication number
CA2005950A1
CA2005950A1 CA2005950A CA2005950A CA2005950A1 CA 2005950 A1 CA2005950 A1 CA 2005950A1 CA 2005950 A CA2005950 A CA 2005950A CA 2005950 A CA2005950 A CA 2005950A CA 2005950 A1 CA2005950 A1 CA 2005950A1
Authority
CA
Canada
Prior art keywords
cdna
antigen protein
genome rna
virus
hepatitis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2005950A
Other languages
English (en)
Other versions
CA2005950C (fr
Inventor
Shunji Mishiro
Tetsuo Nakamura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immuno Japan Inc
Original Assignee
Shunji Mishiro
Tetsuo Nakamura
Immuno Japan Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shunji Mishiro, Tetsuo Nakamura, Immuno Japan Inc. filed Critical Shunji Mishiro
Publication of CA2005950A1 publication Critical patent/CA2005950A1/fr
Application granted granted Critical
Publication of CA2005950C publication Critical patent/CA2005950C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1081—Togaviridae, e.g. flavivirus, rubella virus, hog cholera virus
    • C07K16/109—Hepatitis C virus; Hepatitis G virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333—Saccharide [e.g., DNA, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002005950A 1988-12-21 1989-12-19 Arn du genome du virus de l'hepatie non a, non b, adn-c et proteine antigenique du virus Expired - Fee Related CA2005950C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP63322547A JPH02167081A (ja) 1988-12-21 1988-12-21 非Ａ非Ｂ型肝炎ウイルスゲノムＲＮＡ、ｃＤＮＡおよびウイルス抗原蛋白質
JPSHOWA63NEN322547 1988-12-21

Publications (2)

Publication Number Publication Date
CA2005950A1 true CA2005950A1 (fr) 1990-06-21
CA2005950C CA2005950C (fr) 1996-06-11

Family

ID=18144889

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002005950A Expired - Fee Related CA2005950C (fr) 1988-12-21 1989-12-19 Arn du genome du virus de l'hepatie non a, non b, adn-c et proteine antigenique du virus

Country Status (10)

Country Link
US (1) US5077193A (fr)
EP (1) EP0377303B1 (fr)
JP (1) JPH02167081A (fr)
AT (1) ATE81357T1 (fr)
CA (1) CA2005950C (fr)
DE (1) DE68903165T2 (fr)
DK (1) DK648689A (fr)
ES (1) ES2045475T3 (fr)
GR (1) GR3006171T3 (fr)
IE (1) IE63306B1 (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6171782B1 (en) 1987-11-18 2001-01-09 Chiron Corporation Antibody compositions to HCV and uses thereof
US5712088A (en) * 1987-11-18 1998-01-27 Chiron Corporation Methods for detecting Hepatitis C virus using polynucleotides specific for same
US5698390A (en) * 1987-11-18 1997-12-16 Chiron Corporation Hepatitis C immunoassays
US6861212B1 (en) 1987-11-18 2005-03-01 Chiron Corporation NANBV diagnostics and vaccines
US5714596A (en) * 1987-11-18 1998-02-03 Chiron Corporation NANBV diagnostics: polynucleotides useful for screening for hepatitis C virus
US5350671A (en) * 1987-11-18 1994-09-27 Chiron Corporation HCV immunoassays employing C domain antigens
US5824649A (en) * 1988-06-17 1998-10-20 Genelabs Technologies, Inc. DNA sequences of enterically transmitted non-A/non-B hepatitis viral agent and characteristic epitopes thereof
US5789559A (en) * 1988-06-17 1998-08-04 Genelabs Technologies, Inc. DNA sequences of enterically transmitted non-A/non-B hepatitis viral agent
US5191064A (en) * 1988-09-30 1993-03-02 The Research Foundation For Microbial Diseases (Osaka University) Non-a, non-b hepatitis virus antigen peptide
US6027729A (en) * 1989-04-20 2000-02-22 Chiron Corporation NANBV Diagnostics and vaccines
US5372928A (en) * 1989-09-15 1994-12-13 Chiron Corporation Hepatitis C virus isolates
HUT56883A (en) 1989-12-18 1991-10-28 Wellcome Found Process for producing virus polypeptides
US7166287B1 (en) 1989-12-18 2007-01-23 Glaxo Wellcome Inc. Viral agent
US5747339A (en) * 1990-06-25 1998-05-05 Research Foundation For Microbial Diseases Of Osaka Non-A, non-B hepatitis virus genomic CDNA and antigen polypeptide
EP0544838A4 (en) * 1990-08-25 1997-09-10 New York Blood Center Inc Non-a, non-b hepatitis virus antigen, diagnostic methods and vaccines
US7863008B2 (en) 1990-08-25 2011-01-04 Bioprocess Pty Ltd. Method for detecting NANBV associated seroconversion
US5574132A (en) * 1991-04-05 1996-11-12 Biochem Immunosystems Inc. Peptides and mixtures thereof for detecting antibodies to hepatitis C virus (HCV)
EP0516270A3 (en) * 1991-04-10 1993-06-23 Immuno Japan Inc. Non-a, non-b hepatitis virus related antigen, antibody, detection systems, polynucleotides and polypeptides
WO1994018217A1 (fr) * 1993-02-03 1994-08-18 Abbott Laboratories Reactifs des hepatites non-a, non-b, non-c, non-d, non-e et leurs procedes d'utilisation
US5859230A (en) * 1992-07-30 1999-01-12 Genelabs Technologies, Inc. Non-A/non-B/non-C/non-D/non-E hepatitis agents and molecular cloning thereof
ATE179459T1 (de) * 1992-11-27 1999-05-15 Innogenetics Nv Verfahren zur typisierung von hcv-isolaten
US7258977B1 (en) 1992-11-27 2007-08-21 Innogenetics N.V. Process for typing of HCV isolates
US5874563A (en) * 1994-05-20 1999-02-23 Genelabs Technologies, Inc. Hepatitis G virus and molecular cloning thereof
US5824507A (en) * 1994-05-20 1998-10-20 Genelabs Technologies, Inc. Hepatitis G virus and molecular cloning thereof
US6127116A (en) 1995-08-29 2000-10-03 Washington University Functional DNA clone for hepatitis C virus (HCV) and uses thereof
US7235394B1 (en) 1995-08-29 2007-06-26 Washington University Functional DNA clone for hepatitis C virus (HCV) and uses thereof
US7338759B1 (en) 1997-03-04 2008-03-04 Washington University HCV variants
US7049428B1 (en) * 1998-03-04 2006-05-23 Washington University HCV variants
US6586584B2 (en) 2001-01-29 2003-07-01 Becton, Dickinson And Company Sequences and methods for detection of Hepatitis C virus
US7196183B2 (en) * 2001-08-31 2007-03-27 Innogenetics N.V. Hepatitis C virus genotype, and its use as prophylactic, therapeutic and diagnostic agent
US8124747B2 (en) * 2003-08-29 2012-02-28 Innogenetics HCV clade and prototype sequences thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3744242A1 (de) * 1987-02-20 1989-07-06 Seelig Renate Virusantigen, verfahren zu seiner gewinnung und anwendung in diagnose und therapie (impfstoff)
WO1989004669A1 (fr) * 1987-11-18 1989-06-01 Chiron Corporation Diagnostic et vaccins du virus d'hepatite non-a non-b
IL91371A0 (en) * 1988-08-24 1990-04-29 Us Commerce Clones or vectors bearing dna sequences of non-a and non-b hepatitis and a method for detecting these materials in blood

Also Published As

Publication number Publication date
DE68903165D1 (de) 1992-11-12
DE68903165T2 (de) 1993-03-11
JPH02167081A (ja) 1990-06-27
US5077193A (en) 1991-12-31
DK648689D0 (da) 1989-12-19
ATE81357T1 (de) 1992-10-15
CA2005950C (fr) 1996-06-11
EP0377303A1 (fr) 1990-07-11
GR3006171T3 (fr) 1993-06-21
DK648689A (da) 1990-06-22
IE63306B1 (en) 1995-04-05
IE894083L (en) 1990-06-21
ES2045475T3 (es) 1994-01-16
EP0377303B1 (fr) 1992-10-07

Similar Documents

Publication Publication Date Title
CA2005950A1 (fr) Arn du genome du virus de l'hepatie non a, non b, adn-c et proteine antigenique du virus
EP0423239A4 (en) Post-transfusion, non-a, non-b hepatitis virus and antigens
NZ236491A (en) Post-transfusional non-a non-b hepatitis viral polypeptides, dna, antigenic polypeptides and antibodies to the polypeptides
CA2110058A1 (fr) Polypeptides du virus de l'hepatite c (vhc)
AU6860891A (en) Non-a, non-b hepatitis virus genomic cdna and antigen polypeptide
EP0058676A4 (fr) Effet et vaccin d'hepatite non-a, non-b.
AU652941B2 (en) Non-A, Non-B hepatitis virus particles
GB2108527B (en) Non-a non-b hepatitis virus
AU631490B2 (en) Peptides immunochemically reactive with antibodies directed against hepatitis non-a, non-b virus
AU3857489A (en) Enterically transmitted non-a/non-b hepatitis viral agent
EP0532167A3 (en) Non-a, non-b hepatitis virus genome, polynucleotides, polypeptides, antigen, antibody and detection systems
AU4193789A (en) Detection of non-a, non-b hepatitis
EP0747482A3 (fr) Protéines récombinantes de virus de l'hépatite GB et leur utilisations
AU6030290A (en) Antigenic protein specific for blood-propagated non-a non-b hepatitis, dna wich codes for said protein, and method of producing said protein
AU8156594A (en) Non-A non-B sequences
ZA8410091B (en) Detection of non-a,non-b hepatitis
AU3347393A (en) Peptides immunochemically reactive with antibodies directed against hepatitis non-A, non-B virus
EP0593291A3 (fr) Protéine nonstructurale du virus de l'hépatite C, et méthode diagnostique et nécessaire.
EP0628572A3 (fr) ADN d'origine d'un gène d'un virus de l'hepatite non-A, non-B et polypeptide constituant.
NO950527D0 (no) Analogifremgangsmåte ved fremstilling av non-A, non-B hepatittvirus-antigenpeptid
DE3175439D1 (en) Non-a, non-b hepatitis assay and vaccine
CA2162134A1 (fr) Virus de l'hepatite c, types 4,5 et 6
NZ235402A (en) Detection of non-a, non-b hepatitis, reagents and kits
ZA905502B (en) Blood-borne non-a,non-b hepatitis specific antigenic protein,a dna coding for the protein and a process for producing the protein
NO912459D0 (no) Non-a non-b hepatittviruspartikler.

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed